TMJ Disorders Market Highlights

The TMJ Disorders Market was valued USD 758 Million in 2030. Further, the worldwide market is anticipated to account for a CAGR of 7.10 % between the forecast period of 2022 to 2030.

TMJ disorders are commonly known as temporomandibular joint and muscle disorders. This is a medical condition that causes dysfunction and pain in the jaw joint and the muscles that control jaw movement. It is more common in women than men. Factors that drive the market growth are rising introduction and rapid adoption of advanced treatments, easy availability of medicines, increasing prevalence of TMJ disorders, and rise in healthcare spending worldwide.

TMJ disorders market are the second-most commonly occurring musculoskeletal conditions resulting in pain and disability. The incidence of TMJ peaks from the age of 20-40 years, and it is found to be more prevalent in women than men. Moreover, women who use supplemental estrogenic or oral contraceptives are more likely to seek treatment for these conditions. Therefore, the rising prevalence of these disorders in these populations is propelling the market growth. Several research studies focused on studying the prevalence of TMJ disorders market trends are anticipated to drive market growth. For instance, a prevalence study was conducted in 2016 among the university students of North Saudi Arabia which reported a high prevalence rate among these students. Clicking and pain were the most prevalent finding of TMD, with females having more of these symptoms. A similar study was published in the Indian Association of Public Health Dentistry in 2016 to estimate the prevalence of TMD and its association with parafunctional habits among senior-secondary school children of Lucknow, India. The habits, especially digit-sucking, nail-biting, mouth breathing, and clenching, had statistically significantly associated with TMD. Such research studies are fuelling the market growth of TMJ disorders.

Segment Analysis

Global TMJ Disorders Market, based on Type, is segmented into Myofascial Pain, Internal Derangement (ID), and Osteoarthritis.

The global TMJ disorders market, based on treatment, is segmented into medication, therapies, surgical microscopes, and others.

The medication segment is further sub-segmented into pain relief medication, anti-inflammatories, tricyclic antidepressants, muscle relaxants, and others.

Based on end user, the global TMJ disorders market is categorized into hospitals and clinics, ambulatory surgery canters, academic institutes, and others.

Regional Analysis

Global TMJ Disorder Market insights has been segmented based on regions into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas market has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The market in Europe has been segmented into Western Europe and Eastern Europe. The Western Europe TMJ disorder market is further classified into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. The TMJ disorder market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia-Pacific. The Middle East & Africa TMJ disorder market has been divided into the Middle East and Africa. The Americas held the largest market share of 49.20% of the TMJ disorder market in 2019. This share can be attributed to the introduction and rapid adoption of advanced treatments in the region.

Asia-Pacific is anticipated to register the highest growth rate over the forecast period from 2020 to 2027. This is owing to the high incidence of TMJ disorder, increased government initiative, and the presence of many pharmaceutical companies. Various initiatives taken by the government to support the healthcare system are also fuelling the growth of the regional market.

TMJ Disorders Market Players

Global TMJ Disorder Market players are AbbVie Inc. (US), Allergan (Republic of Ireland), Bayer AG (Germany), Bristol-Myers Squibb Company (US), Jubilant Cadista (US), Pfizer Inc. (US), and Sun Pharmaceutical Industries Ltd. (India).

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com